Clinical Trial Update: Role of Cardiac Biomarkers in Prediction of Outcome in Atrial Fibrillation Patients Undergoing Catheter Ablation

View source ↗

Summary

A completed clinical trial evaluates whether cardiac biomarkers can predict outcomes in patients with atrial fibrillation undergoing catheter ablation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: Texas Cardiac Arrhythmia Research Foundation | Conditions: Atrial Fibrillation | Status: COMPLETED